CORONAVIRUS

Pfizer asks US officials to OK promising COVID-19 pill

Nov 16, 2021, 1:01 PM
Pfizer Inc. signage is seen on July 22, 2020, in New York City. (Photo by Jeenah Moon/Getty Images)...
Pfizer Inc. signage is seen on July 22, 2020, in New York City. (Photo by Jeenah Moon/Getty Images)
(Photo by Jeenah Moon/Getty Images)

WASHINGTON (AP) — Pfizer said Tuesday it is asking U.S. regulators to authorize its experimental pill for COVID-19, setting the stage for a likely launch of the promising therapy in the coming weeks.

The company’s filing comes as new infections are rising once again, driven mainly by hot spots in states where colder weather is driving more Americans indoors.

It is one of a handful of pills that have recently been shown to significantly cut hospitalizations and deaths among people infected with COVID-19. If authorized by the Food and Drug Administration it could be a major step toward managing the pandemic and returning to normal, offering an easy, effective way for patients people to treat themselves at home.

“We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application,” said Albert Bourla, Pfizer’s CEO, in a statement.

All FDA authorized treatments against COVID-19 require an IV or injection given by a health professional at a hospital or clinic.

FDA regulators will scrutinize company data on the safety and effectiveness of the drug, which will be sold as Paxlovid, before making a decision.

The FDA is holding a public meeting later this month where outside experts will scrutinize a competing drug from Merck, before voting on whether to recommend approval. The FDA isn’t required to convene such meetings and it’s not yet known whether Pfizer’s drug will undergo a similar public review.

Some experts predict various COVID-19 therapies eventually will be prescribed in combination to better protect against the worst effects of the virus.

Several smaller drugmakers are also expected to seek authorization for their own antiviral pills in coming months.

Pfizer reported earlier this month that its pill cut hospitalizations and deaths by 89% among high-risk adults who had early symptoms of COVID-19. The company studied its pill in people who were unvaccinated and faced the worst risks from the virus due to age or health problems, such as obesity. If authorized, the FDA will have to weigh making the pill available for vaccinated people dealing with breakthrough infections.

For best results, patients need to start taking the pills within three days of symptoms, underscoring the need for speedy testing and diagnosis. That could be a challenge if another COVID-19 surge leads to testing delays and shortages seen last winter.

Pfizer’s drug is part of a decades-old family of antiviral drugs known as protease inhibitors, which revolutionized the treatment of HIV and hepatitis C. The drugs block a key enzyme which viruses need to multiply in the human body. That’s different than the Merck pill, which causes tiny mutations in the coronavirus until the point that it can’t reproduce itself.

On Tuesday, Pfizer signed a deal a with U.N.-backed group to allow generic drugmakers to produce low-cost versions of the drug for use in 95 countries, a move that could make the treatment available in more than half of the world’s population.

The U.S. has approved one other antiviral drug for COVID-19, remdesivir, and authorized three antibody therapies that help the immune system fight the virus. But they usually have to be given via time-consuming infusions at hospitals or clinics, and limited supplies were strained by the last surge of the delta variant.

___

Follow Matthew Perrone on Twitter: @AP_FDAwriter

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

KSL 5 TV Live

Top Stories

Coronavirus

...
Ashley Moser

Flu, COVID and RSV all trending down for the first time in months, says CDC

Major respiratory illnesses are all trending down for the first time since September, according to the CDC.
8 days ago
FILE PHOTO (Photo by Matthew Hatcher/Getty Images)...
Josh Ellis

Utah doctor, others charged with running COVID vaccine scheme, issuing fake records and giving fake shots

A Utah plastic surgeon, his medical corporation and three others have been charged after prosecutors say they issued fake COVID-19 vaccination record cards and injected minors with saline shots.
14 days ago
Dr. Angela Dunn, executive director of Salt Lake County Health Department, left, discusses schoolch...
Michael Houck

Salt Lake County ends its COVID-19 emergency status

After nearly three years, the Salt Lake County Health Department ended its COVID emergency status Tuesday. 
22 days ago
FILE: People line up in their cars as members of the Utah National Guard give COVID-19 swab tests a...
Eliza Pace

Gov. Cox, along with 24 other governors, call on President Biden to end Federal Public Health Emergency

Gov. Spencer Cox signed a letter with 24 other governors calling on President Joe Biden to end the federal public health emergency over the COVID-19 pandemic.
1 month ago
U.S. President Joe Biden welcomes guests to the East Room of the White House on December 14, 2022 i...
ZEKE MILLER, AP White House Correspondent

White House reveals winter COVID-19 plans, more free tests

The Biden administration is again making some free COVID-19 tests available to all U.S. households as it unveils its contingency plans for potential coronavirus surges this winter.
2 months ago
FILE - Florida Gov. Ron DeSantis speaks during a news conference, Feb. 1, 2022, in Miami. Gov. DeSa...
FREIDA FRISARO, Associated Press

DeSantis seeks grand jury investigation of COVID-19 vaccines

Florida Gov. Ron DeSantis is asking the state’s Supreme Court to convene a grand jury to investigate “any and all wrongdoing” with respect to the COVID-19 vaccines.
2 months ago

Sponsored Articles

Fiber Optical cables connected to an optic ports and Network cables connected to ethernet ports...
Brian Huston, CE and Anthony Perkins, BICSI

Why Every Business Needs a Structured Cabling System

A structured cabling system benefits businesses by giving you faster processing speeds and making your network more efficient and reliable.
notebook with password notes highlighted...
PC Laptops

How to Create Strong Passwords You Can Actually Remember

Learn how you can create strong passwords that are actually easy to remember! In a short time you can create new ones in seconds.
house with for rent sign posted...
Chase Harrington, president and COO of Entrata

Top 5 Reasons You May Want to Consider Apartment Life Over Owning a Home

There are many benefits of renting that can be overshadowed by the allure of buying a home. Here are five reasons why renting might be right for you.
Festive kitchen in Christmas decorations. Christmas dining room....
Lighting Design

6 Holiday Decor Trends to Try in 2022

We've rounded out the top 6 holiday decor trends for 2022 so you can be ahead of the game before you start shopping. 
Happy diverse college or university students are having fun on their graduation day...
BYU MBA at the Marriott School of Business

How to Choose What MBA Program is Right for You: Take this Quiz Before You Apply!

Wondering what MBA program is right for you? Take this quiz before you apply to see if it will help you meet your goals.
Diverse Group of Energetic Professionals Team Meeting in Modern Office: Brainstorming IT Programmer...
Les Olson

Don’t Let a Ransomware Attack Get You Down | Protect Your Workplace Today with Cyber Insurance

Business owners and operators should be on guard to protect their workplace. Cyber insurance can protect you from online attacks.
Pfizer asks US officials to OK promising COVID-19 pill